Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
79 studies found for:    urology AND mayo clinic | Open Studies | null
Show Display Options
Rank Status Study
1 Recruiting Renal Mass Registry
Condition: Renal Cell Carcinoma
Intervention: Other: questionnaire
2 Recruiting Silver-impregnated Suprapubic Catheters (SPC) in Urogynecology
Conditions: Infection Associated With Catheter;   Urinary Tract Infection
Interventions: Device: silver SPC;   Device: standard SPC
3 Recruiting Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study
Condition: Kidney, Polycystic, Autosomal Dominant
Intervention: Procedure: video thorascopic splanchnicectomy (VSPL)
4 Recruiting Senescence in Chronic Kidney Disease
Condition: Chronic Kidney Disease
Interventions: Drug: Group 2: Dasatinib;   Drug: Group 2: Quercetin
5 Recruiting Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN)
Condition: Acute Interstitial Nephritis
Interventions: Drug: Omalizumab;   Drug: Prednisone
6 Recruiting Evaluation of the Relationship Between Vaginal and Lower Urinary Tract Microbiomes and Infection After Hysterectomy
Conditions: Pelvic Organ Prolapse;   Hysterectomy;   Urinary Tract Infection
Intervention:
7 Recruiting Use of Tamsulosin to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery
Condition: Postoperative Urinary Retention
Interventions: Drug: Tamsulosin hydrochloride;   Other: Placebo
8 Recruiting Prevention and Early Detection and Intervention of Post-Coronary Artery Bypass Grafting Surgery (CABG) Acute Kidney Injury (AKI)
Conditions: Acute Renal Injury;   Preventive Measures
Intervention: Procedure: Standard of Care plus Nephrology Care
9 Recruiting A Study to Evaluate INSTILADRIN® in Patients With High Grade, Bacillus Calmette-Guerin (BCG) Unresponsive NMIBC
Condition: Superficial Bladder Cancer
Intervention: Biological: INSTILADRIN
10 Recruiting Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)
Conditions: Cardiomyopathy;   Renal Impairment
Interventions: Drug: Tadalafil;   Drug: Placebo
11 Recruiting Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Systolic Cardiomyopathy (Aim2)
Conditions: Cardiomyopathy;   Renal Impairment
Interventions: Drug: Tadalafil;   Drug: Placebo
12 Not yet recruiting Reduction of Plasma Free VEGF-A Using Low-dose Bevacizumab in Hemodialysis Patients
Conditions: End Stage Renal Disease;   Hemodialysis Vascular Access Failure
Interventions: Drug: 1.25mg bevacizumab;   Drug: 2.50mg bevacizumab
13 Recruiting Role Of Phosphorus And FGF 23 In Patients With Dent Disease
Condition: Dent Disease
Intervention: Drug: Phosphorus Supplement
14 Not yet recruiting Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery
Conditions: Infiltrating Bladder Urothelial Carcinoma;   Stage II Bladder Urothelial Carcinoma;   Stage III Bladder Urothelial Carcinoma;   Stage IV Bladder Urothelial Carcinoma
Interventions: Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Procedure: Radical Cystectomy;   Biological: Tumor Cell-Derived Vaccine Therapy
15 Recruiting Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
Conditions: Stage II Breast Cancer;   Stage IIIA Breast Cancer
Interventions: Procedure: Axillary Lymph Node Dissection (ALND);   Radiation: Nodal Radiation Therapy;   Radiation: Axillary Radiation Therapy
16 Recruiting Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Conditions: Advanced Malignant Neoplasm;   Cervical Squamous Cell Carcinoma;   Endometrial Carcinoma;   Malignant Uterine Neoplasm;   Recurrent Bladder Carcinoma;   Recurrent Breast Carcinoma;   Recurrent Cervical Carcinoma;   Recurrent Head and Neck Carcinoma;   Recurrent Malignant Neoplasm;   Recurrent Ovarian Carcinoma;   Recurrent Prostate Carcinoma;   Recurrent Renal Cell Carcinoma;   Solid Neoplasm;   Stage III Bladder Cancer;   Stage III Prostate Cancer;   Stage III Renal Cell Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIC Breast Cancer;   Stage IIIC Ovarian Cancer;   Stage IV Breast Cancer;   Stage IV Ovarian Cancer;   Stage IV Prostate Cancer;   Stage IV Renal Cell Cancer;   Stage IVA Bladder Cancer;   Stage IVA Cervical Cancer;   Stage IVB Bladder Cancer;   Stage IVB Cervical Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Nanoparticle Albumin-Bound Rapamycin;   Other: Quality-of-Life Assessment
17 Recruiting Hypoxia and Inflammatory Injury in Human Renovascular Hypertension
Conditions: Renal Artery Stenosis;   Ischemic Nephropathy;   Renovascular Disease;   Chronic Kidney Disease
Interventions: Drug: Mesenchymal stem cell;   Procedure: Mesenchymal stem cell delivery with stent placement
18 Recruiting Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer
Conditions: Carcinoma of the Collecting Ducts of Bellini;   Chromophobe Renal Cell Carcinoma;   Kidney Medullary Carcinoma;   Kidney Oncocytoma;   Metastatic Renal Cell Cancer;   Papillary Renal Cell Carcinoma;   Recurrent Renal Cell Carcinoma;   Sarcomatoid Renal Cell Carcinoma;   Stage IV Renal Cell Cancer
Intervention: Drug: Pazopanib Hydrochloride
19 Recruiting CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function
Condition: "Cardiorenal Syndrome (CRS)"
Interventions: Drug: Candesartan;   Drug: Placebo
20 Recruiting Rare Kidney Stone Consortium Biobank
Conditions: Primary Hyperoxaluria;   Dent Disease;   APRT Deficiency;   Cystinuria
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.